Policy makers who are creating initiatives to prevent the very costly and too frequent trips some patients take to the hospital may be examining a population that is actually smaller than they might realize.
Policy makers who are creating initiatives to prevent the very costly and too frequent trips some patients take to the hospital may be examining a population that is actually smaller than they might realize.
In a study published by Health Affairs, researchers found that super-utilizers, or patients who accumulate numerous emergency room visits and hospital admissions over a year span, made up just 3% of the 4774 adults examined in the study. Although they did account for 30% of adult charges.
Less than half of the adults who were characterized as super-utilizers at the start of the study were no longer labeled as such within 7 months from the start. By the end of the year, only 28% of adults in the super-utilizer group were still identified as a hospital frequent flyer. Most patient subgroups reduced their utilization when compared a year later, with the reduction in per person spending averaging 44%.
Of the super-utilizer group, researchers found that 82% of the adults had multiple comorbid chronic conditions, which includes mental health conditions.
“Instability in individual super-utilizer status has important implications for program design,” the authors wrote. “Interventions for individuals who have persistently high utilization are likely to be different from those for individuals with time-limited episodes of super-utilization.”
Recent policy initiatives have been looking to implement community and primary care-based interventions that are less expensive as a means to counter the high costs to the healthcare system super-utilizers are imposing.
“Population-level stability obscures significant instability at the individual level, which may have led to oversimplification of the problem in some policy discussions," the authors wrote.
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen